My Store
Mounjaro 2.5mg
Mounjaro 2.5mg
Couldn't load pickup availability
Lose up to 20% body weight
Weekly self-injection pens
Supports healthy weight loss by reducing appetite and making you feel fuller
No subscriptions, lowest price guaranteed
What is Mounjaro?
Mounjaro is an MHRA-approved treatment designed to assist with weight loss for adults aged 18 and over. Originally approved for type 2 diabetes, Mounjaro is now recognised as a powerful aid for weight management, especially when combined with a calorie-reduced diet and regular exercise.
Who can use Mounjaro?
Mounjaro is best suited for adults with a Body Mass Index (BMI) of 30 or higher, or those with a BMI between 27 and 30 who also suffer from weight-related health conditions like prediabetes or high blood pressure. However, it’s crucial to consult your doctor before starting Mounjaro—especially if you have existing health issues or are taking other medications.
Who can't use Mounjaro?
Only some people are candidates for weight loss medications. You should not use Mounjaro if you are allergic to any of the injection ingredients, especially tirzepatide. It is also unsuitable for people under 18.
If you are pregnant or breastfeeding, Mounjaro is not recommended.
If you are being treated for diabetes, you should speak to your doctor about using Mounjaro as it can cause low blood sugar when used with other medicines for type 2 diabetes, such as insulin.
Speak to your doctor before using Mounjaro if you have:
-
an existing health condition that affects the emptying of your stomach, such as severe gastroparesis
-
an eye condition, such as diabetic retinopathy
-
ever had pancreatitis, which is an inflammation of the pancreas
Mounjaro may interact with other medications, so consult your doctor if you take any prescription, over-the-counter drugs or herbal remedies.
Medications are most effective with lifestyle changes, such as a balanced diet and regular exercise. They are not a substitute for healthy living.
Designed for ease of use
Mounjaro comes in an easy-to-use pre-filled injection pen containing various doses of the active ingredient, tirzepatide. Doses of 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg are available.
It is injected under the skin of your stomach area, thigh, or upper arm.
Starting at a dosage of 2.5mg once a week allows you to adapt to the treatment gradually. After 4 weeks, the dose can be increased to 5 mg once weekly. If needed, dose increases can be made in 2.5 mg increments after a minimum of 4 weeks on the current dose. Depending on how you respond to the treatment, the recommended maintenance doses are 5mg, 10mg or 15 mg once weekly. The maximum dose is 15 mg once weekly.
How effective is Mounjaro for weight loss?
Mounjaro has shown impressive results in clinical trials. People who took Mounjaro (tirzepatide) weekly at a dose of 5 mg lost an average of 16.1 kg (35.5 lb) after 72 weeks. Those taking the 10 mg dose lost an average of 22.2 kg (48.9 lb). Participants on the 15 mg dose lost an average of 23.6 kg (52.0 lb) over the same time period. In comparison, those who received a placebo only lost an average of 2.4 kg (5.3 lb) in 72 weeks.
Don’t hesitate to take control of your weight loss journey. Start with Mounjaro today—
What's the difference between Mounjaro and Wegovy?
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Manufacturer | Eli Lilly | Novo Nordisk |
| MHRA Approval | Type 2 diabetes and weight loss and weight management in adults aged 18 and over | Weight loss and weight maintenance, in adults aged 18 and over. First weight loss medication approved to cut heart disease risk by up to 20% in patients with a BMI over 30 |
| Mode of action | GLP-1 receptor agonist and GIP mimetic acting as an appetite suppressant | GLP-1 receptor agonist acting as an appetite suppressant |
| Dosage Range | The starting dose is 2.5mg once weekly. The dose should be increased in 2.5mg increments, every 4 weeks, to a maintenance dose of either 5 mg, 10mg or 15mg once weekly. | Starting dose 0.25 mg once weekly increasing every 4 weeks up to 2.4 mg once weekly |
| Method of Administration | Mounjaro is to be injected subcutaneously in the abdomen, thigh or upper arm | Wegovy is to be injected subcutaneously in the abdomen, thigh or upper arm. |
| Weight Loss Efficacy | Up to 21% to 22.5% at highest dose (comparable to bariatric surgery) | Average of about 15% in adults. Up to 17.4% at highest dose |
| Common Side Effects | Nausea, indigestion, diarrhoea, vomiting, constipation, stomach pain | Nausea, indigestion, diarrhoea, vomiting, constipation, stomach pain |
| Rare Serious Side Effects | Acute pancreatitis, gallbladder issues, low blood sugar, kidney problems. Allergic reaction | Acute pancreatitis, gallbladder issues, low blood sugar, kidney problems. Allergic reaction. |
Share
